Franklin Resources Inc. Decreases Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Franklin Resources Inc. trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,430,615 shares of the medical equipment provider's stock after selling 83,699 shares during the quarter. Intuitive Surgical accounts for about 0.6% of Franklin Resources Inc.'s holdings, making the stock its 27th largest position. Franklin Resources Inc. owned about 1.24% of Intuitive Surgical worth $2,161,164,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. ORG Partners LLC lifted its stake in Intuitive Surgical by 3,411.1% in the 2nd quarter. ORG Partners LLC now owns 316 shares of the medical equipment provider's stock worth $138,000 after purchasing an additional 307 shares in the last quarter. Fiduciary Financial Group LLC bought a new stake in Intuitive Surgical during the second quarter valued at $394,000. Valley National Advisers Inc. increased its stake in Intuitive Surgical by 29.3% in the 2nd quarter. Valley National Advisers Inc. now owns 622 shares of the medical equipment provider's stock worth $276,000 after acquiring an additional 141 shares during the last quarter. Miracle Mile Advisors LLC boosted its position in shares of Intuitive Surgical by 13.4% during the 2nd quarter. Miracle Mile Advisors LLC now owns 1,676 shares of the medical equipment provider's stock valued at $746,000 after acquiring an additional 198 shares during the last quarter. Finally, Pure Financial Advisors LLC grew its holdings in shares of Intuitive Surgical by 2.4% during the second quarter. Pure Financial Advisors LLC now owns 1,506 shares of the medical equipment provider's stock worth $670,000 after purchasing an additional 35 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Down 0.9 %

Intuitive Surgical stock traded down $5.14 on Friday, hitting $539.58. 1,071,210 shares of the stock traded hands, compared to its average volume of 1,439,242. The business's fifty day simple moving average is $520.67 and its 200 day simple moving average is $477.52. The firm has a market cap of $192.19 billion, a P/E ratio of 87.58, a price-to-earnings-growth ratio of 5.35 and a beta of 1.38. Intuitive Surgical, Inc. has a 1 year low of $320.26 and a 1 year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Oppenheimer reaffirmed a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the company an "overweight" rating in a research report on Wednesday. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Finally, Leerink Partners lifted their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $550.28.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 270 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the business's stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company's stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.